The authors examine the effectiveness of an excipient comprised of mannitol, polyvinyl acetate, and crospovidone using model actives loperamide hydrogen chloride and caffeine.
K Meyer-Böhm
Advertisement
K. Meyer-Böhm is a research and development (R&D) manager, BASF
Articles by K Meyer-Böhm
Advertisement
Latest Updated Articles
Development of Orally Disintegrating Tablets Based on a New ExcipientPublished: November 2nd 2008 | Updated:
Advertisement
Advertisement
Trending on Pharmaceutical Technology
1
Building Resilience in Pharma: Our Top 10 Questions from CPHI Frankfurt
2
Everything to Know About Pharmaceutical Tariffs in 2025
3
Challenges for the Global Manufacturing of Vaccines
4
New Dosage Forms and Delivery Systems Driving 505(b)(2) Success
5
